Streptococcus pneumoniae and Haemophilus influenzae at the initial stage of influenza

Misao Takano1, Kyoko Ozaki, Yoshiyuki Nitahara

  • 1Department of Infectious Disease Control and International Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Insights

Drug-resistant Streptococcus pneumoniae and Haemophilus influenzae are common in children with influenza. Current vaccines may prevent some strains, but resistant non-typeable H. influenzae remains a concern.

Area of Science:

  • Pediatric Infectious Diseases
  • Microbiology
  • Vaccinology

Background:

  • Co-infections with Streptococcus pneumoniae and Haemophilus influenzae can increase influenza severity in children.
  • While vaccinations for S. pneumoniae and H. influenzae were introduced in Japan in 2008, detailed characteristics of these pathogens during early influenza infection remain understudied.

Purpose of the Study:

  • To investigate the prevalence, serotypes, and antimicrobial resistance of S. pneumoniae and H. influenzae in children with influenza.
  • To compare findings in influenza-positive children with those in children with upper respiratory tract infections but without influenza.

Main Methods:

  • Nasopharyngeal swabs were collected from children with influenza (n=236) and a control group with upper respiratory tract infections (n=189).
  • Samples were analyzed for bacterial pathogens, including S. pneumoniae and H. influenzae, focusing on serotypes, drug susceptibilities, and resistance genes/mutations.

Main Results:

  • S. pneumoniae, beta-streptococci, Staphylococcus aureus, Moraxella catarrhalis, and H. influenzae were isolated.
  • Prevalent S. pneumoniae serotypes included 3, 6, 19, and 23, with penicillin, macrolide, and clindamycin resistance observed.
  • H. influenzae type b showed significant ampicillin resistance; most isolates were non-typeable. Similar pathogen characteristics were noted in the control group.

Conclusions:

  • Drug-resistant S. pneumoniae (serotypes 19, 23) and H. influenzae type b were present in the early stages of influenza infection, similar to non-influenza URTI cases.
  • Current vaccines may offer protection against some identified strains.
  • The prevalence of drug-resistant, non-typeable H. influenzae is a significant concern requiring further attention.
Abstract

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...